This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: WSG-TP-II Trial - ET + Trastuzumab & Pertuzumab vs. De-Escalated Chemo + Trastuzumab & Pertuzumab in HR+/HER2+ eBC

By ecancer FEATURING Oleg Gluz
By ecancer FEATURING Oleg Gluz
42 views
October 11, 2024
Comments 0
Login to view comments. Click here to Login